Work Here?
Overview
Cognita Artificials combines human experience with a broad AI knowledge base that includes machine learning, neural networks, and data analytics to address modern technology challenges. Its specialists offer comprehensive AI expertise and dedicated IT solutions tailored to an increasingly demanding market. Their approach blends deep technical know-how with practical application, delivering customized AI-driven solutions for clients. Unlike some competitors, Cognita Artificials emphasizes a hands-on, bespoke service that leverages both expert guidance and advanced AI tools to solve real business problems. The company’s goal is to help clients navigate today’s tech landscape by providing tailored AI and IT solutions that meet their specific needs and drive tangible outcomes.
About Cognita
Industries
Data & Analytics
Enterprise Software
AI & Machine Learning
Healthcare
Company Size
N/A
Company Stage
N/A
Total Funding
N/A
Headquarters
Poland
Founded
2018
Get referred to Cognita
See people who can refer or advise you
Simplify's Take
What believers are saying
- Jan. 28, 2026 Stanford AIDE partnership strengthens Cognita's safety credibility.
- March 2026 validation showed 16%-65% detection gains and 18% faster interpretation.
- Mosaic plans Cognita across all X-rays and 3D CT, widening adoption.
What critics are saying
- Cognita remains investigational; FDA breakthrough designation is not clearance.
- Radiology Partners faces 2026 insurer litigation over billing and No Surprises Act disputes.
- A failed pivotal study or FDA delay kills Cognita's 2027 commercialization path.
What makes Cognita unique
- Mar. 5, 2026 FDA breakthrough status makes Cognita first radiology generative-AI model.
- Cognita CXR drafts integrated chest-X-ray findings, not isolated findings alerts.
- Radiology Partners supplies 4,000 radiologists and 55 million annual studies for validation.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Remote Work Options
Hybrid Work Options
Company News
Cognita, the AI business unit of Mosaic Clinical Technologies, has received FDA Breakthrough Device Designation for its Cognita Chest X-Ray system, a generative vision-language model designed to assist radiologists in interpreting chest X-rays. It is the first radiology generative AI model to receive this designation. The system analyses chest X-rays and generates comprehensive preliminary findings for radiologist review. Internal clinical validation showed participating radiologists achieved enhanced detection of up to 16-65% for certain significant findings and an 18% boost in average interpretation efficiency. Mosaic Clinical Technologies is a wholly-owned subsidiary of Radiology Partners, the largest radiology practice in the US with over 4,000 radiologists. The FDA's Breakthrough Device Programme accelerates development of technologies that may significantly improve patient care for life-threatening conditions.
Amid an acute and worsening global shortage of radiologists, driven by rising imaging demand, limited residency growth and accelerated workforce attrition, M...
Cognita is Hiring for 2 Jobs on Simplify!
Find jobs on Simplify and start your career today
About Cognita
Industries
Data & Analytics
Enterprise Software
AI & Machine Learning
Healthcare
Company Size
N/A
Company Stage
N/A
Total Funding
N/A
Headquarters
Poland
Founded
2018
Cognita is Hiring for 2 Jobs on Simplify!
Find jobs on Simplify and start your career today